OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Publication Date
Release Date
2024
(4)
2021
(4)
2022
(3)
2025
(2)
2023
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Circulating androgen receptor gene amplification and resistance to
177
Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial.
Not available
S-EPMC8548293
|
biostudies-literature
Cite
Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials.
Not available
S-EPMC8219772
|
biostudies-literature
Cite
Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis.
Not available
S-EPMC8155858
|
biostudies-literature
Cite
Treatments and Outcomes in Neuroendocrine Patients Treated with Long-Acting Somatostatin Analogues: An Italian Real-World Propensity Score-Matched Cohort Study.
Not available
S-EPMC11852996
|
biostudies-literature
Cite
177
Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials.
Not available
S-EPMC9776442
|
biostudies-literature
Cite
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors.
Not available
S-EPMC9346628
|
biostudies-literature
Cite
Recommendations on the Clinical Application and Future Potential of α-Particle Therapy: A Comprehensive Review of the Results from the SECURE Project.
Not available
S-EPMC12567000
|
biostudies-literature
Cite
Radioligand therapies in cancer: mapping the educational landscape in Europe.
Not available
S-EPMC10102677
|
biostudies-literature
Cite
Lutetium [
177
Lu]-DOTA-TATE in gastroenteropancreatic-neuroendocrine tumours: rationale, design and baseline characteristics of the Italian prospective observational (REAL-LU) study.
Not available
S-EPMC11368969
|
biostudies-literature
Cite
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors
Not available
S-EPMC9895371
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets